LUMINESCE: A Phase 3 Study Evaluating Satralizumab, a Therapeutic Recycling Antibody Targeting the IL-6 Receptor, in Patients with Generalized Myasthenia Gravis
ANNALS OF NEUROLOGY(2022)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
ANNALS OF NEUROLOGY(2022)